• Happy Holidays from Cafepharma! To allow its staff to spend holiday time with their families, the Cafepharma Message Boards will be switched to read-only from 6:00 PM Eastern time on Tuesday, December 24 until 10:00 PM Eastern time on Wednesday, December 25. During this time, all posts will be available for view. However, no one will be able to make new posts during this time.


Kaleo can't stay out of trouble









































































anonymous said:
That's because most of the company's sales aren't "real" sales. At least, they are not sales that will benefit the bottom line. The company's higher-ups don't want to show that to anyone (internal or external). They may show the number of injectors going out the door, but that's about it.

The company is barely covered by commercial insurance companies, and the majority of "sales" are offset by the kaleo itself. So kaleo is actually covering the most of its patient's pharmacy cost for the injectors. It is hidden in the gross-to-net section of the financials, either through specialty pharmacies or consignment. Most of the revenue that the company earns, that makes it to the bottom line, is from the federal government (medicaid, medicare, VA and DoD).

If you have ever heard a drug commercial that states,,,

" if you you can't afford 'drug name', then 'company name' may be able to help ",,,

or something close to that wording. That is what kaelo is doing, but to a much greater extent than most other drug companies. It can help get medication into the hands of a patient, it doesn't help the bottom line.
Click to expand...
This was written in 2019, here we are 5 years later and nothing has changed.
 
















































You must log in or register to reply here.
Top Bottom
Back